Maybe there is something to a short attack but hon
Post# of 148170
Safety from lack of SAEs caused by leronlimab was pretty much known because of HIV. The data suggests with SAEs not linked to leronlimab that there may have been people that progressed to severe from MM even on leronlimab. I don't know that for a fact because I don't know what the reported SAEs were from people who got the drug. The one death could have been a car accident, we just don't know full details. So I think we got a PR with some numbers but it does not yet contain the true information we were hoping to see and that's efficacy. Any report on SAEs is pure speculation because no one knows what they were except it was stated they were not caused by leronlimab.
Guessing the PR was a rush job to get us something and with expectations at an all time high, they weren't met. I personally think NP, Dr BP, and Dr Jay would call these results very good. I think day traders and regular investors searching for the big miracle drug were not blown away and they move on just like they do with the moderna, novavax, Astra zenecas...who's the latest vaccine in the headlines??? That's the next run up.